Elevated serum transaminases in patients with acute coronary syndromes: Do we need a revision of exclusion criteria for clinical trials?

BACKGROUND: Elevations of hepatic transaminase (serum alanine transaminase [ALT] and serum aspartate aminotransferase [AST]) levels in patients with acute coronary syndrome (ACS), although transient, may result in exclusions from clinical efficacy trials due to suspected liver disease. The aim of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jasiewicz, Małgorzata, Siedlaczek, Michał, Kasprzak, Michał, Gorog, Diana A., Jilma, Bernd, Siller-Matula, Jolanta, Obońska, Karolina, Dobosiewicz, Ryszard, Pstrągowski, Krzysztof, Kubica, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2023
Materias:
Clinical Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635717/
https://www.ncbi.nlm.nih.gov/pubmed/34355781
http://dx.doi.org/10.5603/CJ.a2021.0081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635717/
https://www.ncbi.nlm.nih.gov/pubmed/34355781
http://dx.doi.org/10.5603/CJ.a2021.0081

Ejemplares similares